(NASDAQ: SRRK) Scholar Rock Holding's forecast annual revenue growth rate of 761.49% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 31.51%, and it is also forecast to beat the US market's average forecast revenue growth rate of 12.32%.
Scholar Rock Holding's revenue in 2026 is $570,000.On average, 19 Wall Street analysts forecast SRRK's revenue for 2026 to be $588,427,597, with the lowest SRRK revenue forecast at $191,303,022, and the highest SRRK revenue forecast at $1,281,047,019. On average, 19 Wall Street analysts forecast SRRK's revenue for 2027 to be $17,140,409,114, with the lowest SRRK revenue forecast at $9,098,849,960, and the highest SRRK revenue forecast at $22,802,636,938.
In 2028, SRRK is forecast to generate $46,871,680,358 in revenue, with the lowest revenue forecast at $32,354,367,521 and the highest revenue forecast at $67,527,038,483.